Clinical trial
A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine
NCT00412477 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00412477 |
|---|---|
| Title | A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine |
| Official title | RV 151: A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine LFn-p24 Administered by the Intramuscular (IM) Route in Healthy Adults, WRAIR #984, HSRRB Log # A-11905. |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | Walter Reed Army Institute of Research (WRAIR) U.S. Fed |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological |
| Interventions | HIV LFn-p24 |
| Enrollment | 18 |
| Start date | Aug 20, 2004 |
| Primary completion | Mar 13, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Dec 18, 2006 |
| Last update posted | Oct 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: